These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unilateral Beau's lines associatd with a fingertip crushing injury. Lee YJ; Yun SK J Dermatol; 2005 Nov; 32(11):914-6. PubMed ID: 16361754 [TBL] [Abstract][Full Text] [Related]
5. Images in clinical medicine. Multiple Beau's lines. Park J; Li K N Engl J Med; 2010 May; 362(20):e63. PubMed ID: 20484394 [No Abstract] [Full Text] [Related]
6. Drug-induced nail abnormalities. Piraccini BM; Iorizzo M; Tosti A Am J Clin Dermatol; 2003; 4(1):31-7. PubMed ID: 12477371 [TBL] [Abstract][Full Text] [Related]
7. Beau's lines of the fingernails. Ryu H; Lee HJ Am J Med Sci; 2015 Apr; 349(4):363. PubMed ID: 24667530 [No Abstract] [Full Text] [Related]
8. Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B. Mayer RJ; Davis RB; Schiffer CA; Berg DT; Sarno E; Frei E Leukemia; 1992; 6 Suppl 2():66-7. PubMed ID: 1578945 [No Abstract] [Full Text] [Related]
9. Everest nails: a prospective study on the incidence of Beau's lines after time spent at high altitude. Bellis F; Nickol A High Alt Med Biol; 2005; 6(2):178-80. PubMed ID: 16060852 [TBL] [Abstract][Full Text] [Related]
10. Beau's lines in nails: An indicator of recent Docetaxel and 5-FU use. Chu NS; Wu IC; Chen LT; Chin YY Kaohsiung J Med Sci; 2018 Mar; 34(3):181-183. PubMed ID: 29475467 [No Abstract] [Full Text] [Related]
11. Drug-induced nail abnormalities. Piraccini BM; Iorizzo M; Antonucci A; Tosti A Expert Opin Drug Saf; 2004 Jan; 3(1):57-65. PubMed ID: 14680462 [TBL] [Abstract][Full Text] [Related]
12. Unilateral Beau's lines associated with a fractured and immobilized wrist. Harford RR; Cobb MW; Banner NT Cutis; 1995 Nov; 56(5):263-4. PubMed ID: 8565610 [TBL] [Abstract][Full Text] [Related]
13. Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency. Chim CS; Kwong YL Am J Hematol; 1996 Nov; 53(3):208. PubMed ID: 8895701 [No Abstract] [Full Text] [Related]
14. Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. Lee EJ; George SL; Caligiuri M; Szatrowski TP; Powell BL; Lemke S; Dodge RK; Smith R; Baer M; Schiffer CA J Clin Oncol; 1999 Sep; 17(9):2831-9. PubMed ID: 10561359 [TBL] [Abstract][Full Text] [Related]
15. New agents in the treatment of acute myeloid leukemia. Wiernik PH Semin Hematol; 1991 Jul; 28(3 Suppl 4):95-8. PubMed ID: 1780763 [No Abstract] [Full Text] [Related]
16. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group. Büchner T; Hiddemann W; Löffler G; Gassmann W; Maschmeyer G; Heit W; Hossfeld D; Weh H; Ludwig WD; Thiel E Semin Hematol; 1991 Jul; 28(3 Suppl 4):76-9. PubMed ID: 1780757 [No Abstract] [Full Text] [Related]
17. Chemotherapy-induced multiple Beau's lines. Singh M; Kaur S Int J Dermatol; 1986 Nov; 25(9):590-1. PubMed ID: 3793359 [No Abstract] [Full Text] [Related]